Free Trial

Omron (OTCMKTS:OMRNY) Shares Gap Up - Time to Buy?

Omron logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Omron's shares gapped up premarket from $32.61 to an open of $35.75 and last traded at $35.81, trading well above its 50‑day ($30.53) and 200‑day ($27.97) moving averages.
  • The company missed consensus EPS for the quarter ($0.17 vs. $0.36) while revenue beat estimates ($1.41B vs. $1.38B); management set FY2025 EPS guidance at 0.96 versus analysts' average of 1.22.
  • Zacks upgraded Omron from "strong sell" to "hold" and the consensus rating is Hold, but institutional ownership remains very low (~1.09%) despite a small stake increase by GAMMA Investing.
  • Five stocks to consider instead of Omron.

Omron Corp. (OTCMKTS:OMRNY - Get Free Report)'s stock price gapped up prior to trading on Thursday . The stock had previously closed at $32.61, but opened at $35.75. Omron shares last traded at $35.8050, with a volume of 6,553 shares changing hands.

Analysts Set New Price Targets

Separately, Zacks Research raised Omron from a "strong sell" rating to a "hold" rating in a report on Monday, January 19th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of "Hold".

Get Our Latest Analysis on Omron

Omron Price Performance

The company has a market capitalization of $7.08 billion, a price-to-earnings ratio of 45.57, a P/E/G ratio of 0.38 and a beta of 1.00. The stock has a fifty day simple moving average of $30.53 and a 200-day simple moving average of $27.97. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.11 and a quick ratio of 1.37.

Omron (OTCMKTS:OMRNY - Get Free Report) last announced its earnings results on Thursday, February 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.19). The business had revenue of $1.41 billion for the quarter, compared to analyst estimates of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%.Omron has set its FY 2025 guidance at 0.960-0.960 EPS. On average, equities research analysts anticipate that Omron Corp. will post 1.22 EPS for the current year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC lifted its holdings in shares of Omron Corp. (OTCMKTS:OMRNY - Free Report) by 50.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,129 shares of the company's stock after buying an additional 716 shares during the quarter. GAMMA Investing LLC's holdings in Omron were worth $54,000 as of its most recent SEC filing. Institutional investors own 1.09% of the company's stock.

About Omron

(Get Free Report)

Omron Corporation OTCMKTS: OMRNY is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omron Right Now?

Before you consider Omron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.

While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines